Radiopharm Theranostics has secured the services of United States-based Dr Dimitris Voliotis as its new chief medical officer in a bid to advance the...
Vous n'êtes pas connecté
Will Masimo (MASI) lose its CEO in its fight against activist investor Politan Capital Management? The company's management and employees want Joe Kiani to continue as the CEO.
Radiopharm Theranostics has secured the services of United States-based Dr Dimitris Voliotis as its new chief medical officer in a bid to advance the...
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended June 2024, it might be worth...
Masimo (MASI) receives unsolicited requests from multiple entities for acquiring its consumer business. The company already received a non-binding...
In July, Saarthi AI founder and CEO Vishwa Nath Jha shared with PTI that the company had to lay off employees in a bid to become profitable.
Masimo (MASI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
In an email to employees, Byju Raveendran expressed that each legal hurdle has prolonged the company’s journey toward recovery.
BetterMarkets CEO Dennis Kelleher believes that the SEC could still emerge victorious in its fight against Ripple
Masimo (MASI) delivered earnings and revenue surprises of 11.69% and 0.24%, respectively, for the quarter ended June 2024. Do the numbers hold clues...
RGS Group has applauded the outcome of the vote on Friday by Tongaat Hulett shareholders as a decisive victory for shareholder activism and corporate...
A young activist from Ghana, Emmanuel Beausoleil, is making a name for himself in the fight against climate change.